(S)-4-(3-FLUORO-2-METHYLPHENYL)-4,5-DIHYDROOXAZOL-2-AMINE, 95.0%, 250mg

3-n-Butoxybenzoic acid, 97.0%, 1g

Sodium (S)-6-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide, 97%, 250mg

Cyclohexane, min. 99.5%, for synthesis, 5 l, alu

(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine, 97%, 100mg

5-(2H-1,3-benzodioxol-5-yl)-1H-pyrazole-4-carboxylic acid, 95.0%, 2g

Methyl 2,4-difluoro-3-nitrobenzoate, 98%, 1g

(R)-1-O-TOLYLETHANAMINE, 95.0%, 100mg

2-Amino-4,6-dibromopyrimidine, 95.0%, 250mg

4,4'-Dihydroxy-[1,1'-biphenyl]-3,3'-dicarboxylic acid, 97%, 25g

1-N-Boc-4-Pyrimidin-2-yl-piperazine, 97.0%, 100g

2-Bromo-1-(tert-butyl)-4-chlorobenzene, 95%, 5g

1-(2-Methylmercaptophenyl)piperazine, 500mg